ATE317396T1 - 14,15-beta-methylen substituierte androgene - Google Patents

14,15-beta-methylen substituierte androgene

Info

Publication number
ATE317396T1
ATE317396T1 AT00993259T AT00993259T ATE317396T1 AT E317396 T1 ATE317396 T1 AT E317396T1 AT 00993259 T AT00993259 T AT 00993259T AT 00993259 T AT00993259 T AT 00993259T AT E317396 T1 ATE317396 T1 AT E317396T1
Authority
AT
Austria
Prior art keywords
beta
methylene substituted
androgens
substituted androgens
methylene
Prior art date
Application number
AT00993259T
Other languages
German (de)
English (en)
Inventor
Dirk Leysen
Der Louw Jaap Van
Bursi Roberta Buma
Gooyer Marcel Evert De
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE317396T1 publication Critical patent/ATE317396T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
AT00993259T 1999-12-02 2000-11-29 14,15-beta-methylen substituierte androgene ATE317396T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02

Publications (1)

Publication Number Publication Date
ATE317396T1 true ATE317396T1 (de) 2006-02-15

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00993259T ATE317396T1 (de) 1999-12-02 2000-11-29 14,15-beta-methylen substituierte androgene

Country Status (27)

Country Link
US (1) US6706700B2 (cg-RX-API-DMAC7.html)
EP (1) EP1237904B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003515543A (cg-RX-API-DMAC7.html)
CN (1) CN1166680C (cg-RX-API-DMAC7.html)
AR (1) AR026655A1 (cg-RX-API-DMAC7.html)
AT (1) ATE317396T1 (cg-RX-API-DMAC7.html)
AU (1) AU778017B2 (cg-RX-API-DMAC7.html)
CA (1) CA2390226A1 (cg-RX-API-DMAC7.html)
CO (1) CO5251441A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106086T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ301376B6 (cg-RX-API-DMAC7.html)
DE (1) DE60025958T2 (cg-RX-API-DMAC7.html)
DK (1) DK1237904T3 (cg-RX-API-DMAC7.html)
ES (1) ES2258037T3 (cg-RX-API-DMAC7.html)
HK (1) HK1047596B (cg-RX-API-DMAC7.html)
HU (1) HUP0203611A3 (cg-RX-API-DMAC7.html)
IL (1) IL149424A (cg-RX-API-DMAC7.html)
MX (1) MXPA02004939A (cg-RX-API-DMAC7.html)
NO (1) NO322422B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ518753A (cg-RX-API-DMAC7.html)
PE (1) PE20011033A1 (cg-RX-API-DMAC7.html)
PL (1) PL202999B1 (cg-RX-API-DMAC7.html)
RU (1) RU2242479C2 (cg-RX-API-DMAC7.html)
SK (1) SK287095B6 (cg-RX-API-DMAC7.html)
TW (1) TWI275593B (cg-RX-API-DMAC7.html)
WO (1) WO2001040255A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200203536B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
PL208163B1 (pl) * 2002-01-21 2011-03-31 Organon Nv Sposób wytwarzania 7 α-metylosteroidów
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
EA024003B1 (ru) * 2011-10-07 2016-08-31 Эстетра С.П.Р.Л. Способ получения эстетрола
PT3310333T (pt) 2015-06-18 2020-06-08 Estetra Sprl Dose unitária orodispersível contendo um composto de estetrol
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
CA2988362C (en) 2015-06-18 2022-07-19 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
TN2017000499A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) * 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
CA2359218A1 (en) 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens

Also Published As

Publication number Publication date
ZA200203536B (en) 2003-08-04
AU778017B2 (en) 2004-11-11
CY1106086T1 (el) 2011-06-08
SK287095B6 (sk) 2009-12-07
PL355689A1 (en) 2004-05-17
CZ301376B6 (cs) 2010-02-03
AR026655A1 (es) 2003-02-19
DE60025958D1 (de) 2006-04-20
NO20022564L (no) 2002-05-30
US6706700B2 (en) 2004-03-16
NO20022564D0 (no) 2002-05-30
RU2242479C2 (ru) 2004-12-20
HUP0203611A3 (en) 2004-07-28
CN1402735A (zh) 2003-03-12
DE60025958T2 (de) 2006-07-27
DK1237904T3 (da) 2006-06-06
EP1237904B1 (en) 2006-02-08
NZ518753A (en) 2004-05-28
MXPA02004939A (es) 2003-05-23
HK1047596B (en) 2006-04-21
TWI275593B (en) 2007-03-11
HK1047596A1 (en) 2003-02-28
US20030100543A1 (en) 2003-05-29
CZ20021894A3 (cs) 2002-08-14
IL149424A0 (en) 2002-11-10
SK7582002A3 (en) 2002-09-10
WO2001040255A2 (en) 2001-06-07
AU2838301A (en) 2001-06-12
IL149424A (en) 2007-05-15
EP1237904A2 (en) 2002-09-11
CO5251441A1 (es) 2003-02-28
JP2003515543A (ja) 2003-05-07
CN1166680C (zh) 2004-09-15
ES2258037T3 (es) 2006-08-16
CA2390226A1 (en) 2001-06-07
WO2001040255A3 (en) 2001-11-15
HUP0203611A2 (hu) 2003-03-28
PL202999B1 (pl) 2009-08-31
NO322422B1 (no) 2006-10-02
PE20011033A1 (es) 2001-10-11

Similar Documents

Publication Publication Date Title
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
IS6024A (is) Ný efnasambönd
EE200200033A (et) Uued ühendid
ID28483A (id) 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
EE04089B1 (et) 1,3,4-oksadiasolooni derivaadid
MXPA01011760A (es) Compuestos novedosos de difeniletileno.
ATE234839T1 (de) 4,5-azolo-oxindole
NO20022927L (no) Substituerte pyrrazoler
EP1192168A4 (en) galectin
DE50003921D1 (de) Substituierte phenyluracile
ES1042496Y (es) "pilona sumible".
ES1044367Y (es) Piñata mejorada.
DE60017150D1 (de) 1,4,5,6 -tetrahydropyrimidine-derivative als vitronectin-hemmer
ES1044013Y (es) Nueva cantonera mejorada.
SE9901602D0 (sv) Jet-tröska 2000
SE9900910D0 (sv) FreezeBox 2000
ID30507A (id) Diarilamina tersubstitusi 1-heterosiklus
ES1042809Y (es) Esponja-estropajo mejorado.
IT1313922B1 (it) Elettromandrino perfezionato.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1237904

Country of ref document: EP

REN Ceased due to non-payment of the annual fee